Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q1 2025 Earnings

C2RS34.SA
Feb 11Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-8.52
-6.53
-4.53
-2.54

Details

Expected EPS
-6.921112338
Actual EPS
-2.53638
Surprise EPS
4.38
Surprise Percent
+63.35%

Description

⁨CRISPR Therapeutics⁩ (⁦C2RS34.SA⁩) has reported earnings of ⁦-2.53638⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts